首页> 外文期刊>Neuro-Oncology >Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [~(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas
【24h】

Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [~(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas

机译:使用动态[〜(18)F] FET-PET成像预测WHO II和III级脑胶质瘤的少突神经胶质组织学和LOH 1p / 19q

获取原文
获取原文并翻译 | 示例
           

摘要

Oligodendroglial components (OC) and loss of hetero-zygosity on chromosomes lp and 19q (LOH lp/19q) are associated with better outcome in patients with glioma. We aimed to assess the fitness of [~(18)F]fluoroethyltyrosine positron-emission-tomography (FET-PET) for noninvasively identifying these important prognostic/predictive factors. One hundred forty-four patients with MRI-suspected WHO grade II and III glioma underwent FET-PET scans prior to histologi-cal diagnosis. FET-PET analyses included maximal tumoral uptake (SUV_(max)/BG), biological tumor volume (BTV), mean tumoral uptake (SUV_(mean)/BG), total tumoral uptake (SUV_(total)/BG), and kinetic analysis. Suspicion of OC was based on static and dynamic FET-uptake parameters. PET results were correlated with histology and lp/19q status. OC tumors exhibited significantly higher uptake values, compared with astro-cytomas (AC) (SUV_(max)/BG 3.1 vs 2.3, BTV 15.5 mL vs 7.2 mL, SUV_(total)/BG 38.5 vs 17.4, P<.01 each; SUV_(mean)/BG 2.2 vs 2.1, P<.05). These differences were more pronounced in WHO grade II gliomas. Comparable results were found with respect to lp/19q status. Kinetic analysis misclassified 18 of 34 low-grade OC tumors as high-grade glioma but misclassified only 5 of 45 of the low-grade ACs. FET-based suspicion of OC resulted in concordance rates of both 76% for the prediction of OC and LOH lp/19q. FET-uptake was significantly higher in gliomas with OC, compared with AC, and likewise in lp/19q codeleted, compared with noncodeleted tumors. However, FET-PET analysis did not reliably predict the presence of OC/LOH lp/ 19q in the individual patient, mostly because of an overlap in PET characteristics of OC tumors and high-grade AC. Histological examination is still required for an accurate diagnosis.
机译:胶质瘤患者中,少突胶质成分(OC)和染色体1p和19q(LOH lp / 19q)染色体杂合性的丧失与较好的预后相关。我们旨在评估[〜(18)F]氟乙基酪氨酸正电子发射断层扫描(FET-PET)的适用性,以无创地确定这些重要的预后/预测因素。 144例经MRI怀疑是MRI的WHO胶质瘤患者在进行组织学诊断之前接受了FET-PET扫描。 FET-PET分析包括最大肿瘤吸收(SUV_(max)/ BG),生物肿瘤体积(BTV),平均肿瘤吸收(SUV_(mean)/ BG),总肿瘤吸收(SUV_(total)/ BG)和动力学分析。 OC的怀疑基于静态和动态FET吸收参数。 PET结果与组织学和lp / 19q状态相关。与星形细胞瘤(AC)相比,OC肿瘤的摄取值明显更高(SUV_(max)/ BG 3.1 vs 2.3,BTV 15.5 mL vs 7.2 mL,SUV_(total)/ BG 38.5 vs 17.4,P <.01; SUV_(平均)/ BG 2.2 vs 2.1,P <.05)。这些差异在WHO II级神经胶质瘤中更为明显。发现关于lp / 19q状态的可比结果。动力学分析将34个低度OC肿瘤中的18个错误分类为高级神经胶质瘤,但将45个低度AC仅仅分类了5个。基于FET的OC怀疑导致OC和LOH lp / 19q的预测一致率均为76%。与AC相比,OC胶质瘤中FET的摄取显着更高,与未编码的胶质瘤相比,在已编码的lp / 19q中,FET的摄取也更高。但是,FET-PET分析不能可靠地预测个体患者中OC / LOH lp / 19q的存在,这主要是因为OC肿瘤和高级别AC的PET特征重叠。仍需要组织学检查以进行准确诊断。

著录项

  • 来源
    《Neuro-Oncology》 |2012年第12期|1473-1480|共8页
  • 作者单位

    Department of Nuclear Medicine Hospital of the Ludwig-Maximilians-University, Munich;

    Department of Neurosurgery Hospital of the Ludwig-Maximilians-University, Munich;

    Department of Nuclear Medicine Hospital of the Ludwig-Maximilians-University, Munich;

    Center for Neuropathology and Prion Research Hospital of the Ludwig-Maximilians-University, Munich;

    Department of Neuroradiology, Hospital of the Ludwig-Maximilians-University, Munich;

    Center for Neuropathology and Prion Research Hospital of the Ludwig-Maximilians-University, Munich;

    Department of Nuclear Medicine, Katharinenhospital, Stuttgart, Germany;

    Center for Neuropathology and Prion Research Hospital of the Ludwig-Maximilians-University, Munich;

    Department of Nuclear Medicine Hospital of the Ludwig-Maximilians-University, Munich;

    Department of Nuclear Medicine Hospital of the Ludwig-Maximilians-University, Munich;

    Department of Neurosurgery Hospital of the Ludwig-Maximilians-University, Munich;

    Department of Neurosurgery Hospital of the Ludwig-Maximilians-University, Munich;

    Department of Nuclear Medicine, University of Munich, Marchioninistrasse 15, D-81377 Munich, Germany;

    Department of Neurosurgery Hospital of the Ludwig-Maximilians-University, Munich;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    FET-PET; FET uptake; glioma; kinetic analysis; LOHlp/19q; oligodendroglial tumor components;

    机译:场效应PET FET吸收;胶质瘤动力学分析LOHlp / 19q;少突神经胶质瘤成分;

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号